TW224101B - - Google Patents

Info

Publication number
TW224101B
TW224101B TW082104989A TW82104989A TW224101B TW 224101 B TW224101 B TW 224101B TW 082104989 A TW082104989 A TW 082104989A TW 82104989 A TW82104989 A TW 82104989A TW 224101 B TW224101 B TW 224101B
Authority
TW
Taiwan
Prior art keywords
anomer
beta
ribofuranosyl sulfonate
sulfonate
ribofuranosyl
Prior art date
Application number
TW082104989A
Other languages
English (en)
Chinese (zh)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of TW224101B publication Critical patent/TW224101B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW082104989A 1992-06-22 1993-06-22 TW224101B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/902,305 US5256798A (en) 1992-06-22 1992-06-22 Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates

Publications (1)

Publication Number Publication Date
TW224101B true TW224101B (enExample) 1994-05-21

Family

ID=25415655

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082104989A TW224101B (enExample) 1992-06-22 1993-06-22

Country Status (14)

Country Link
US (1) US5256798A (enExample)
EP (1) EP0577302B1 (enExample)
JP (1) JP3379993B2 (enExample)
AT (1) ATE155476T1 (enExample)
BR (1) BR9302429A (enExample)
CA (1) CA2098882C (enExample)
DE (1) DE69312176T2 (enExample)
DK (1) DK0577302T3 (enExample)
ES (1) ES2105114T3 (enExample)
GR (1) GR3024975T3 (enExample)
HU (1) HU216832B (enExample)
IL (1) IL106077A (enExample)
MX (1) MX9303712A (enExample)
TW (1) TW224101B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69311000T2 (de) * 1992-06-22 1997-11-27 Lilly Co Eli Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
US5424416A (en) * 1993-08-25 1995-06-13 Eli Lilly And Company Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
SG158136A1 (en) * 2004-09-14 2010-01-29 Pharmasset Inc Preparation of 2`-fluoro-2`- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
CA2598895A1 (en) * 2005-03-04 2006-09-08 Dabur Pharma Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides
BRPI0610950A2 (pt) * 2005-06-03 2010-08-03 Scinopharm Taiwan Ltd processo para produção de um sulfonato de 2-deoxi-2, 2-difluoro-d-ribofuranosil enriquecido de alfa anÈmero, e uso do mesmo para produção de um beta nocleosìdeo
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
AT502221A1 (de) * 2005-07-20 2007-02-15 Pharmacon Forschung & Beratung Gmbh Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
WO2007092705A2 (en) * 2006-02-07 2007-08-16 Chemagis Ltd. Process for preparing gemcitabine and associated intermediates
US20070249823A1 (en) * 2006-04-20 2007-10-25 Chemagis Ltd. Process for preparing gemcitabine and associated intermediates
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
CN101024667B (zh) * 2007-03-30 2011-01-26 湖北益泰药业有限公司 盐酸吉西他宾的合成方法
US20080262215A1 (en) * 2007-04-23 2008-10-23 Chemagis Ltd. Gemcitabine production process
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
BRPI0923815A2 (pt) * 2008-12-23 2015-07-14 Pharmasset Inc Síntese de nucleosídeos de purina
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
SI3290428T1 (sl) 2010-03-31 2022-01-31 Gilead Pharmasset Llc Tableta, ki obsega kristalinični (S)-izopropil 2-(((S)-(((2R,3R,4R,5R) -5-(2,4-diokso-3,4-dihidropirimidin-1(2H)-il)-4-fluoro-3-hidroksi-4- metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
WO2015030853A1 (en) 2013-08-27 2015-03-05 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
CN103692332B (zh) * 2013-12-31 2015-12-09 景宁畲族自治县通用机械配件厂（普通合伙） 全自动抛光除油机
CN107793334A (zh) * 2017-09-27 2018-03-13 九江善水科技股份有限公司 芳基磺酸铵盐化合物、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3856158T2 (de) * 1987-08-28 1998-08-20 Lilly Co Eli Verfahren zur Herstellung von Zwischenverbindungen verwendbar in der Herstellung von 2',2'-Difluoronucleosiden
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides

Also Published As

Publication number Publication date
DE69312176D1 (de) 1997-08-21
HU216832B (hu) 1999-09-28
HUT65207A (en) 1994-05-02
JP3379993B2 (ja) 2003-02-24
CA2098882A1 (en) 1993-12-23
ATE155476T1 (de) 1997-08-15
IL106077A0 (en) 1993-10-20
MX9303712A (es) 1994-05-31
ES2105114T3 (es) 1997-10-16
DK0577302T3 (da) 1997-10-06
CA2098882C (en) 2004-05-04
US5256798A (en) 1993-10-26
EP0577302A1 (en) 1994-01-05
EP0577302B1 (en) 1997-07-16
JPH0656865A (ja) 1994-03-01
BR9302429A (pt) 1994-01-11
IL106077A (en) 1998-07-15
GR3024975T3 (en) 1998-01-30
HU9301825D0 (en) 1993-09-28
DE69312176T2 (de) 1997-12-11

Similar Documents

Publication Publication Date Title
TW224101B (enExample)
HU9302452D0 (en) Method for anomerizating nucleosides
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
HU206683B (en) Process for producing 1,5-diphenyl-pyrazolo-3-carboxylic acid derivatives and selective herbicide compositions containing them as antidotum
BR9302428A (pt) Processo estereosseletivo a baixa temperatura para preparar um derivado enriquecido de riboturanosila alfa-anomero e o derivado obitdo
NO932286L (no) Stereoselektiv anion-glykosyleringsprosess
IL106075A0 (en) Process for preparing alpha-anomer enriched 1-halo-2-deoxy-2,2-difluoro-d-ribofuranosyl derivatives
HUT64551A (en) A method for spearating 2-desoxi-2,2-difluorine-d-ribo furanosyle-alkyl-sulfonate anomers
GR3022477T3 (en) Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates.
DE3560750D1 (en) Process for the preparation of high molecular poly(arylene sulfides) which may be branched
GR3018063T3 (en) Process for preparation of phosphatidylcholine derivatives.
ES2127249T3 (es) Procedimiento para preparar 2-desoxi-2,2-difluoro-d-ribofuranosil-arilsulfonatos enriquecidos en el anomero beta.
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
HUT38345A (en) Process for producing 4,5,6,7-tetrahydrofuro- or -1h-pyrrolo/2,3-c/pyridine derivatives and pharmaceutical compositions containing them
GB8908173D0 (en) Process for purifying 4,4'-dihydroxydiphenyl sulfone
EP0188373A3 (en) Macrolide derivatives
IL102144A0 (en) Process for producing 2'-deoxy-2',2'-difluoro nucleosides
YU69087A (en) Process for selective alkylizing of alphanaphtole by using inter-phase homogenous catalysis
RO102313B1 (en) Process to recrystallize erythromycin